Market Overview:
The global tuberculin syringe market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of tuberculosis (TB) and rising demand for better diagnostic tools for TB. Based on type, the global tuberculin syringe market can be segmented into rigid pack tuberculin syringes and softpack tuberculin syringes. The rigid pack tuberculin syringes segment is expected to account for a larger share of the global market than the softpack tuberculin syringes segment during the forecast period.
Product Definition:
A tuberculin syringe is a medical device used to inject substances into or withdraw fluids from the body. It is a type of hypodermic needle that is specifically designed for use with tuberculin, an antigen preparation made from cultures of Mycobacterium tuberculosis. The vaccine antigen is used to test for immunity to tuberculosis (TB), and also as part of treatment for the disease.
Rigid Pack Tuberculin Syringes:
Rigid Pack Tuberculin Syringes (RPT) are used for the diagnosis of Tuberculosis. Rigid pack is a term used for syringes that contain medication in the form of TB drugs and has no diluent with it. It consists of one or more drug or combination of drugs that are to be administered to a patient.
SoftPack Tuberculin Syringes:
The SoftPack Tuberculin Syringes are used for the administration of anti-TB drug, is also known as Tuberculosis Anti-Lymphatic Reticulin (TALR) vaccine. It helps in reducing the risk of developing active and latent tuberculosis infection in people with HIV.
Application Insights:
Based on application, the global tuberculosisculin syringe market is segmented into hospital and clinic. The hospital segment dominated the market in 2017 owing to factors such as increasing prevalence of TB, government initiatives for controlling TB infection through mass drug administration (MDA) and expansion of diagnostic centers. For instance, according to WHO estimates published in 2018, there were 10 million new cases of TB worldwide with about 1.3 million deaths due to the disease annually. In addition, according to data published by CDC in September 2018 regarding MDA activities globally from 2015-2016 to 2017-2018 period, U.S.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers coupled with high awareness levels and favorable government initiatives is expected to drive the regional demand. For instance, in 2015, Pfizer Inc., through its subsidiary Genentech developed a new tuberculosis vaccine that was subsequently launched as Xolair under FDA approval in 2016. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing incidence rates of drug-resistant tuberculosis coupled with growing healthcare expenditure levels and improving infrastructure facilities within developing countries such as India and China.
Growth Factors:
- Increasing incidence of tuberculosis (TB) across the globe is expected to drive the tuberculin syringe market growth.
- Rising demand for better diagnosis and treatment of TB is also anticipated to fuel the tuberculin syringe market growth in the near future.
- Growing number of private diagnostic laboratories and hospitals is projected to create lucrative opportunities for tuberculin syringe manufacturers in forthcoming years.
- Technological advancements in medical devices industry are likely to offer new opportunities for players operating in tuberculin syringe market during forecast period 2017-2025
Scope Of The Report
Report Attributes
Report Details
Report Title
Tuberculin Syringe Market Research Report
By Type
Rigid Pack Tuberculin Syringes, SoftPack Tuberculin Syringes
By Application
Hospital, Clinic
By Companies
BD(Becton Dickinson)(Singapore), CardioMed Supplies(Canada), McKesson Medical-Surgical(USA), ZARYS(Poland), Cardinal Health(USA), Crosstex(USA), EXEL(USA), Kendall Monoject(USA)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
182
Number of Tables & Figures
128
Customization Available
Yes, the report can be customized as per your need.
Global Tuberculin Syringe Market Report Segments:
The global Tuberculin Syringe market is segmented on the basis of:
Types
Rigid Pack Tuberculin Syringes, SoftPack Tuberculin Syringes
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD(Becton Dickinson)(Singapore)
- CardioMed Supplies(Canada)
- McKesson Medical-Surgical(USA)
- ZARYS(Poland)
- Cardinal Health(USA)
- Crosstex(USA)
- EXEL(USA)
- Kendall Monoject(USA)
Highlights of The Tuberculin Syringe Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rigid Pack Tuberculin Syringes
- SoftPack Tuberculin Syringes
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tuberculin Syringe Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A tuberculin syringe is a medical device that is used to inject purified Tuberculosis (TB) bacteria into the skin. TB bacteria are killed by the immune system, so this injection helps prevent TB from spreading in the body.
Some of the major companies in the tuberculin syringe market are BD(Becton Dickinson)(Singapore), CardioMed Supplies(Canada), McKesson Medical-Surgical(USA), ZARYS(Poland), Cardinal Health(USA), Crosstex(USA), EXEL(USA), Kendall Monoject(USA).
The tuberculin syringe market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tuberculin Syringe Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tuberculin Syringe Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tuberculin Syringe Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tuberculin Syringe Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tuberculin Syringe Market Size & Forecast, 2020-2028
4.5.1 Tuberculin Syringe Market Size and Y-o-Y Growth
4.5.2 Tuberculin Syringe Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Rigid Pack Tuberculin Syringes
5.2.2 SoftPack Tuberculin Syringes
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tuberculin Syringe Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tuberculin Syringe Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Rigid Pack Tuberculin Syringes
9.6.2 SoftPack Tuberculin Syringes
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Rigid Pack Tuberculin Syringes
10.6.2 SoftPack Tuberculin Syringes
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Rigid Pack Tuberculin Syringes
11.6.2 SoftPack Tuberculin Syringes
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Rigid Pack Tuberculin Syringes
12.6.2 SoftPack Tuberculin Syringes
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Rigid Pack Tuberculin Syringes
13.6.2 SoftPack Tuberculin Syringes
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tuberculin Syringe Market: Competitive Dashboard
14.2 Global Tuberculin Syringe Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD(Becton Dickinson)(Singapore)
14.3.2 CardioMed Supplies(Canada)
14.3.3 McKesson Medical-Surgical(USA)
14.3.4 ZARYS(Poland)
14.3.5 Cardinal Health(USA)
14.3.6 Crosstex(USA)
14.3.7 EXEL(USA)
14.3.8 Kendall Monoject(USA)
